The iron chelator deferoxamine decreases myeloma cell survival

OBJECTIVE: This study evaluated serum ferritin (SF) levels and investigated their relationships with various clinical markers in patients with multiple myeloma (MM). Furthermore, the effects and molecular mechanism of deferoxamine (DFO) in myeloma cells were studied. METHODS: Clinical data from 84 p...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Feifei, Wu, Zhaoxian, Dai, Dan, Zhang, Lei, Zhang, Xiuqun, Zhang, Xuezhong, Xu, Yanli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Retrospective Clinical Research Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7841871/
https://www.ncbi.nlm.nih.gov/pubmed/33478296
http://dx.doi.org/10.1177/0300060520987396

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7841871/
https://www.ncbi.nlm.nih.gov/pubmed/33478296
http://dx.doi.org/10.1177/0300060520987396

Ejemplares similares